Clearside Biomedical (CLSD) Misses Q1 EPS by 1c

Clearside Biomedical (NASDAQ: CLSD) reported Q1 EPS of ($0.15), $0.01 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $4 million versus the consensus estimate of $154 thousand.

For earnings history and earnings-related data on Clearside Biomedical (CLSD) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c
• Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c